SENSEX
NIFTY
GOLD
USD/INR

Weather

image 39    C

Company News

The Economic Times

Company / The Economic Times

details

Weight-loss drugmaker Lilly nears $1.97 bn AtaiBeckley's acquisition: Report

Eli Lilly is reportedly negotiating to acquire psychedelic drugmaker AtaiBeckley. AtaiBeckley shares experienced a significant surge following the news of these discussions. The company focuses on mental health treatments using psychedelic-based compounds. AtaiBeckley is developing an intranasal formulation for treatment-resistant depression. Talks are ongoing, and a deal could be announced this week.

16 Jul 2026 10:31 am